MLYS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MLYS shares is 153, representing 100.99% of the company's common stock.

N/A, in the last quarter, reduced its stake in MLYS by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the MLYS shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned MLYS shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, N/A increased its stake in MLYS by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of MLYS to its portfolio, raising its holding to - shares of worth -. N/A also increased its MLYS shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in MLYS is Slingsby Brian Taylor , at the company. Additionally, MLYS stock is highly held by 10 percent owner Samsara BioCapital GP, LLC and 10 percent owner HBM Healthcare Investments (Cayman) Ltd. among others.

Company executives, directors, and other insiders own 2.52% percent of Mineralys Therapeutics, Inc.'s stock. Within the last six months, there have been 6 transaction(s) in which MLYS insiders have sold stock, totaling 74.97K shares. Insiders that have sold shares include CONGLETON JON, LEVY ADAM SCOTT, and RODMAN DAVID MALCOM.

There have been 0 transaction(s) during the past 6-months in which Mineralys Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 2.51M Mineralys Therapeutics, Inc. shares are held by insiders, which represents about 2.52% of MLYS stock.

MLYS , Slingsby Brian Taylor holds the largest portfolio of the company's shares. MLYS shares owned by Slingsby total nearly 8.64 million.

N/A is the largest institutional owner in MLYS which holds - shares worth - or N/A of the total MLYS shares outstanding followed by N/A with ownership of - shares representing N/A of the MLYS ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MLYS is concerned, it is a stock which is optionable.

Number of MLYS shares short is 1.83M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 49.77M shares of MLYS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MLYS has 23.86M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MLYS is 9.68.